Similarly, combined inhibition of CAIX and GPX4 using the ferroptosis inducer RSL3 synergistically enhanced ferroptosis and co-targeting of CAIX activity and GSH synthesis in vivo decreased tumour growth and increased survival through a ferrroptosis-mediated mechanism (Venkateswaran et al., 2023). This evidence concerns the gene GPX4 and neoplasm.